PLK1 inhibitor TAK-960
Term · Oncology and biomedicine · MLC-T-ONC-016119
An orally available, Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor TAK-960 selectively inhibits PLK1, inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells. PLK1 inhibition may result in the inhibition of proliferation in PLK1-overexpressed tumor cells. PLK1, named after the polo gene of Drosophila melanogaster, is a serine/threonine kinase crucial in the regulation of mitosis.
| Identifier | MLC-T-ONC-016119 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Polo-like kinase 1 inhibitor TAK-960 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016119",
"term": "PLK1 inhibitor TAK-960",
"field": "Oncology and biomedicine",
"definition": "An orally available, Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor TAK-960 selectively inhibits PLK1, inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells. PLK1 inhibition may result in the inhibition of proliferation in PLK1-overexpressed tumor cells. PLK1, named after the polo gene of Drosophila melanogaster, is a serine/threonine kinase crucial in the regulation of mitosis.",
"synonyms": [
"Polo-like kinase 1 inhibitor TAK-960"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/plk1-inhibitor-tak-960/"
}
Record 13,361 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.